These phenotypes share common mechanisms of sodium retention yet differ in their dominant pathophysiologic drivers, diagnostic challenges, and therapeutic vulnerabilities, enabling a more individualized and mechanistically informed treatment strategy
However, semaglutide benefits extend to patients without diabetes who struggle with weight management complicated by conditions like hypertension, dyslipidemia, sleep apnea, or nonalcoholic fatty liver disease
AstraZeneca signed a licensing agreement with Chinese biotech company Eccogene to develop an obesity pill
Genetic astrocytopathies Alexander disease Alexander disease, or AxD (named after its discoverer W
A large molecule such as a peptide is primarily localized within the central compartment, and thus a small volume of distribution is expected
A new consumer: how weight-loss drugs are shaking up clothes shopping Im now at a point where Im going to buy even more clothes, says Hayley Grice, 50, from Shropshire, who has dropped seven sizes after starting on the GLP-1 weight loss jab Mounjaro two years ago
